Details of the Drug Reposition

General Information of This Drug (ID: DM28UJG)

Drug Name
Dapagliflozin   DM28UJG
Synonyms BMS 512148; BMS-512148; BMS-512148, Dapagliflozin; Dapagliflozin (INN/USAN); 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Approved [1]
Non-insulin dependent diabetes DISK1O5Z 5A11 Approved [2]
------------------------------------------------------------------------------------

References

1 Dapagliflozin in Respiratory Failure in Patients With COVID-19 (DARE-19)
2 Dapagliflozin FDA Label